K-103-PA Phase 3 study
Phase 3
- Conditions
- Soft tissue pain
- Registration Number
- JPRN-jRCT2080221217
- Lead Sponsor
- Kowa Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 340
Inclusion Criteria
Soft tissue pain
Exclusion Criteria
1.Patients with history of allergy to indometacin medication
2.Patients with active skin lesions at the intended site of application of the study medication, with bad skin condition, with dermal hypersensitivity
Etc
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy, safety<br>VAS pain score, adverse event
- Secondary Outcome Measures
Name Time Method Efficacy, safety<br>VAS pain score, global improvement rating, global assessment of study medication satisfaction, adverse event